Pathologists / Introduction / General Information / Staff / Map / Flow Cytometry
Histopathology / Cytopathology / Hematopathology / PLA Home Page

Revised Bethesda System 2001

Back to PAP smear reporting

SPECIMEN TYPE: Indicate conventional smear (Pap smear) vs. liquid-based vs. other

SPECIMEN ADEQUACY

  • Satisfactory for evaluation (describe presence or absence of endocervical/transformation zone component and any other quality indicators, e.g. partially obscuring blood, inflammation, etc.)
  • Unsatisfactory for evaluation ... (specify reason)
  • Specimen rejected/not processed (specify reason)
  • Specimen processed and examined, but unsatisfactory for evaluation of epithelial abnormality because of (specify reason)

GENERAL CATEGORIZATION

  • Negative for Intraepithelial Lesion or Malignancy
  • Epithelial Cell Abnormality: See Interpretation/Result (specify ‘squamous’ or ‘glandular’ as
    appropriate)
  • Other: See Interpretation/Result (e.g. endometrial cells in a woman > 40 years of age)

AUTOMATED REVIEW: If case examined by automated device, specify device and result. (i.e., Focal Point® TriPath Imaging™ Primary Screening System)

ANCILLARY TESTING: Provide a brief description of the test methods and report the result so that it is easily understood by the clinician.

INTERPRETATION/RESULT

  • NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY (When there is no cellular evidence of
    neoplasia, state this in the General Categorization above and/or in the Interpretation/Result section of the report, whether or not there are organisms or other non-neoplastic findings)
  • ORGANISMS:
    • Trichomonas vaginalis
    • Fungal organisms morphologically consistent with Candida spp
    • Shift in flora suggestive of bacterial vaginosis
    • Bacteria morphologically consistent with Actinomyces spp.
    • Cellular changes consistent with Herpes simplex virus
  • OTHER NON-NEOPLASTIC FINDINGS (Optional to report; list not inclusive):
    • Reactive cellular changes associated with inflammation (includes typical repair)
    • Radiation
    • Intrauterine contraceptive device (IUD)
    • Glandular cells status post hysterectomy
    • Atrophy
  • OTHER: Endometrial cells (in a woman > 40 years of age) (Specify if ‘negative for squamous intraepithelial lesion’)
  • EPITHELIAL CELL ABNORMALITIES:

SQUAMOUS CELL

Atypical squamous cells

    • of undetermined significance (ASC-US
    • cannot exclude HSIL (ASC-H)

Low grade squamous intraepithelial lesion (LSIL)

    • Encompassing: HPV/mild dysplasia/CIN 1

High grade squamous intraepithelial lesion (HSIL)

    • Encompassing: moderate and severe dysplasia, CIN 2 and CIN 3/CIS
      with features suspicious for invasion (if invasion is suspected)
    • Squamous cell carcinoma

GLANDULAR CELL

Atypical

    • Endocervical cells (NOS or specify in comments)
    • Endometrial cells (NOS or specify in comments)
    • Glandular cells (NOS or specify in comments)

Atypical favor neoplastic

    • Endocervical cells, favor neoplastic
    • Glandular cells, favor neoplastic
    • Endocervical adenocarcinoma in situ (AIS)

Adenocarcinoma

    • Endocervical
    • Endometrial
    • Extrauterine not otherwise specified (NOS) OTHER MALIGNANT NEOPLASMS: (specify EDUCATIONAL NOTES AND SUGGESTIONS (optional)

Back to PAP smear reporting


 Copyright © 1998-2007 Pathology Laboratories of Arkansas, P.A.